167 related articles for article (PubMed ID: 38316675)
1. Correlation between choroid plexus carcinoma and Li-Fraumeni syndrome: implications of TP53 mutations and management strategies-a case-based narrative review.
Mallik D; Gopal S; Scalia G; Umana G; Rajeswarie RT; Chaurasia B
Childs Nerv Syst; 2024 Jun; 40(6):1699-1705. PubMed ID: 38316675
[TBL] [Abstract][Full Text] [Related]
2. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
Tabori U; Shlien A; Baskin B; Levitt S; Ray P; Alon N; Hawkins C; Bouffet E; Pienkowska M; Lafay-Cousin L; Gozali A; Zhukova N; Shane L; Gonzalez I; Finlay J; Malkin D
J Clin Oncol; 2010 Apr; 28(12):1995-2001. PubMed ID: 20308654
[TBL] [Abstract][Full Text] [Related]
3. Case Report : Li-Fraumeni Syndrome with Central Nervous System Tumors in Two Siblings.
Fang Z; Su Y; Sun H; Ge M; Qi Z; Hao C; Qian S; Ma X
BMC Pediatr; 2021 Dec; 21(1):588. PubMed ID: 34961499
[TBL] [Abstract][Full Text] [Related]
4. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010.
Gozali AE; Britt B; Shane L; Gonzalez I; Gilles F; McComb JG; Krieger MD; Lavey RS; Shlien A; Villablanca JG; Erdreich-Epstein A; Dhall G; Jubran R; Tabori U; Malkin D; Finlay JL
Pediatr Blood Cancer; 2012 Jun; 58(6):905-9. PubMed ID: 21990040
[TBL] [Abstract][Full Text] [Related]
5. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy for choroid plexus carcinoma patients with Li-Fraumeni syndrome: advantageous or detrimental?
Bahar M; Kordes U; Tekautz T; Wolff J
Anticancer Res; 2015 May; 35(5):3013-7. PubMed ID: 25964589
[TBL] [Abstract][Full Text] [Related]
7. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Mai PL; Best AF; Peters JA; DeCastro RM; Khincha PP; Loud JT; Bremer RC; Rosenberg PS; Savage SA
Cancer; 2016 Dec; 122(23):3673-3681. PubMed ID: 27496084
[TBL] [Abstract][Full Text] [Related]
8. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
9. Contribution of de novo and mosaic
Renaux-Petel M; Charbonnier F; Théry JC; Fermey P; Lienard G; Bou J; Coutant S; Vezain M; Kasper E; Fourneaux S; Manase S; Blanluet M; Leheup B; Mansuy L; Champigneulle J; Chappé C; Longy M; Sévenet N; Paillerets BB; Guerrini-Rousseau L; Brugières L; Caron O; Sabourin JC; Tournier I; Baert-Desurmont S; Frébourg T; Bougeard G
J Med Genet; 2018 Mar; 55(3):173-180. PubMed ID: 29070607
[TBL] [Abstract][Full Text] [Related]
10. Choroid Plexus Carcinomas With TP53 Germline Mutations: Management and Outcome.
Li Y; Liu H; Li T; Feng J; He Y; Chen L; Li C; Qiu X
Front Oncol; 2021; 11():751784. PubMed ID: 34660315
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
[TBL] [Abstract][Full Text] [Related]
12. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
13. Molecular insights into malignant progression of atypical choroid plexus papilloma.
Yankelevich M; Finlay JL; Gorsi H; Kupsky W; Boue DR; Koschmann CJ; Kumar-Sinha C; Mody R
Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608379
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation signature is prognostic of choroid plexus tumor aggressiveness.
Pienkowska M; Choufani S; Turinsky AL; Guha T; Merino DM; Novokmet A; Brudno M; Weksberg R; Shlien A; Hawkins C; Bouffet E; Tabori U; Gilbertson RJ; Finlay JL; Jabado N; Thomas C; Sill M; Capper D; Hasselblatt M; Malkin D
Clin Epigenetics; 2019 Aug; 11(1):117. PubMed ID: 31409384
[TBL] [Abstract][Full Text] [Related]
15. The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome.
Macaulay S; Goodyear QC; Kruger M; Chen W; Essop F; Krause A
Fam Cancer; 2018 Oct; 17(4):607-613. PubMed ID: 29392648
[TBL] [Abstract][Full Text] [Related]
16. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
Kamihara J; Rana HQ; Garber JE
Hum Mutat; 2014 Jun; 35(6):654-62. PubMed ID: 24706533
[TBL] [Abstract][Full Text] [Related]
17. Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
Kumamoto T; Yamazaki F; Nakano Y; Tamura C; Tashiro S; Hattori H; Nakagawara A; Tsunematsu Y
Int J Clin Oncol; 2021 Dec; 26(12):2161-2178. PubMed ID: 34633580
[TBL] [Abstract][Full Text] [Related]
18. The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.
Silva AG; Krepischi AC; Pearson PL; Hainaut P; Rosenberg C; Achatz MI
Orphanet J Rare Dis; 2014 Apr; 9():63. PubMed ID: 24775443
[TBL] [Abstract][Full Text] [Related]
19. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
[TBL] [Abstract][Full Text] [Related]
20. A child with Li-Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignancies.
Schlegelberger B; Kreipe H; Lehmann U; Steinemann D; Ripperger T; Göhring G; Thomay K; Rump A; Di Donato N; Suttorp M
Pediatr Blood Cancer; 2015 Aug; 62(8):1481-4. PubMed ID: 25787918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
